levamisole hydrochloride

PreclinicalSmall molecule

levamisole hydrochloride is one of 22 small molecule programs targeting Severe Aplastic Anemia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Severe Aplastic AnemiaActive, not recruiting

Severe Aplastic AnemiaPreclinical

Active, not recruiting

Competition

Competitive Landscape

25 competitors in Severe Aplastic Anemia

#DrugCompanyPhaseTrials

Neoral

Novartis

Approved

13 2

Fludara

Sanofi

Phase 3

11 3

Promacta

GSK

Phase 3

6 4

Cytoxan

BBaxter Healthcare Corporation

Phase 3

16 5

Doptelet

Atgam

8 7

Cellcept

Roche

Phase 2

3 8

Rabbit ATG

Novartis

Phase 3

3 9

Nplate

Amgen

Phase 2

1 10

Rituxan

Roche

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Severe Aplastic Anemia1 trial

Clinical Study of Non Severe Aplastic Anemia Treated With Cyclosporine, Androgen and Levamisole

Unknown status·SShengyun Lin·N/A·NCT03218657·248 enrolled

Nephrotic Syndrome1 trial

Efficiency of Levamisole for Maintaining Remission After the First Flare of Steroid Sensitive Nephrotic Syndrome in Children

Completed·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT02818738·86 enrolled

Colorectal Cancer1 trial

Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer

Unknown status·EEuropean Institute of Oncology·Phase 3·NCT00003063·1,050 enrolled

Colon Cancer1 trial

Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer

Completed·NNSABP Foundation Inc·Phase 3·NCT00425152·2,151 enrolled

Radiation Therapy1 trial

SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed

Completed·SSWOG Cancer Research Network·Phase 3·NCT00002551·1,917 enrolled

2 more indications

Intrahepatic Cholangiocarcinoma1 trial

Treatment of Advanced Intrahepatic Cholangiocarcinoma

Unknown status·TThe First Affiliated Hospital of Zhengzhou University·Phase 3·NCT03940378·152 enrolled

Chemotherapy1 trial

S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed

Completed·SSWOG Cancer Research Network·Phase 3·NCT00002593·1,135 enrolled

Sources

References

[1]
ClinicalTrials.gov — 7 trial records for levamisole hydrochloride. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — levamisole hydrochloride compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for levamisole hydrochloride. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — SWOG Cancer Research Network company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: SSWOG Cancer Research Network

levamisole hydrochloride

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Severe Aplastic Anemia1 trial

Nephrotic Syndrome1 trial

Colorectal Cancer1 trial

Colon Cancer1 trial

Radiation Therapy1 trial

Intrahepatic Cholangiocarcinoma1 trial

Chemotherapy1 trial

References

Drug Info

Quick Facts

Related News